The Inaugural CRISPR-Based Therapy Analytical Development Summit was the industry’s definitive conference dedicated to satisfying the unmet needs of gene editing analytical development experts.
This rare opportunity showcased your solutions to our audience, uniting directors and analytical development scientists from large pharma and pioneering biotech’s. Attendees became the spearheads in cutting-edge analytical solutions and aligned their brand with industry experts to establish their company as a thought-leaders in the CRISPR space.
Whether it be to reconnect with past clients, explore new business opportunities, or emphasize your presence at the forefront in the field, partners of the CRISRP-Based Therapy Analytical Development Summit are closer to the thought-leaders actively seeking networking and collaborating opportunities to overcome the challenges they face.
Your brand, your message, your reputation – showcased to leading experts in the CRISPR and gene editing field.
2023 Companies in Attendance
*Estimated Attendance Based on CRISPR 2.0*
“This is an unmet need to connect with industry experts and regulatory authorities to discuss analytical method development and control strategy in the emerging CRISPR space. I look forward to attending the inaugural CRISPR-based therapy analytical development to meet with and learn from peer researchers and developers.”
- Zack Zhang, Director at Beam Therapeutics